A PYMNTS Company

US/Ireland: Pharmaceutical buyout nets $4.2B in rare disease treatment business

By  |  November 11, 2013

Ireland-based pharmaceutical company Shire has reportedly inked a deal to acquire U-based ViroPharma for $4.2 billion.

The buyout, reports say, will aid the Irish firm in expanding its business in rare disease treatments.

The companies announced the deal Monday and said they expect to close the merger by the first quarter of 2014 pending regulatory approval.

Full Content: Deal Book

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.